Compare Expeditors International of Wshngtn Inc (EXPD) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expeditors International of Wshngtn Inc vs GSK plc — how do they compare? Expeditors International of Wshngtn Inc trades at $177.4 (market cap $23.04B), while GSK plc trades at $50.55 (market cap $102.60B). The key difference: GSK plc is far larger — about 4.5× Expeditors International of Wshngtn Inc's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| EXPD | GSK | |
|---|---|---|
Market Cap | $23.04B | $102.60B |
Sector | Industrials | Health |
52-Week High | $182.80 | $61.18 |
52-Week Low | $113.13 | $38.22 |
Enterprise Value | $22.57B | $123.04B |
Dividend Yield | 0.91% | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
